Dr. Bryde is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 E Jefferson St
Ste 101
Boise, ID 83712Phone+1 208-223-1680Fax+1 208-322-1695
Summary
- Hypertrophic Cardiomyopathy and Sports Cardiology Fellow
Education & Training
Mercer University School of MedicineClass of 2017
Certifications & Licensure
FL State Medical License 2018 - 2025
ID State Medical License 2024 - 2025
NJ State Medical License 2023 - 2025
MN State Medical License 2022 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- A Multicenter Evaluation of the Impact of Therapies on Deep Learning-Based Electrocardiographic Hypertrophic Cardiomyopathy Markers.Lovedeep S Dhingra, Veer Sangha, Arya Aminorroaya, Robyn Bryde, Andrew Gaballa
The American Journal of Cardiology. 2025-02-15 - Goal-Directed Versus Self-Directed Valsalva Maneuver in Patients With Hypertrophic Cardiomyopathy on Cardiac Myosin Inhibitor Therapy.Aakash Bavishi, Marybeth Soutar, Margaret Kurnides, Heather Speer, Glenda Oyarce
JACC. Advances. 2025-02-01 - Efficacy of Cardiac Myosin Inhibition in Patients After Septal Reduction Therapy.Aakash Bavishi, Robyn Bryde, Marybeth Soutar, Margaret Kurnides, Heather Speer
The American Journal of Cardiology. 2025-01-15
Press Mentions
Advancing the Field: Sports Cardiology, Hypertrophic Cardiomyopathy Highlighted at ACC.23September 27th, 2023- Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin InhibitorsJune 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
